BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, Aoki M, Taketo MM. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A 2010;107:13063-8. [PMID: 20616008 DOI: 10.1073/pnas.1002372107] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang FJ, Zhou XY, Ye L, Fei XC, Wang S, Wang W, Ning G. Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15. BMC Cancer 2016;16:98. [PMID: 26875556 DOI: 10.1186/s12885-016-2114-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Mukaida N, Sasaki S, Baba T. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment. Mediators Inflamm. 2014;2014:170381. [PMID: 24966464 DOI: 10.1155/2014/170381] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
3 Lim SY, Gordon-Weeks AN, Zhao L, Tapmeier TT, Im JH, Cao Y, Beech J, Allen D, Smart S, Muschel RJ. Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis. Oncoimmunology 2013;2:e23187. [PMID: 23802071 DOI: 10.4161/onci.23187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kurzejamska E, Sacharczuk M, Landázuri N, Kovtonyuk O, Lazarczyk M, Ananthaseshan S, Gaciong Z, Religa P. Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors. Int J Mol Sci 2019;20:E686. [PMID: 30764543 DOI: 10.3390/ijms20030686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Terasaki M, Ono S, Hashimoto S, Kubota A, Kojima H, Ohta T, Tanaka T, Maeda H, Miyashita K, Mutoh M. Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin. J Nutr Biochem 2021;99:108871. [PMID: 34571188 DOI: 10.1016/j.jnutbio.2021.108871] [Reference Citation Analysis]
6 Hirai H, Fujishita T, Kurimoto K, Miyachi H, Kitano S, Inamoto S, Itatani Y, Saitou M, Maekawa T, Taketo MM. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis. Clin Exp Metastasis 2014;31:977-89. [PMID: 25326065 DOI: 10.1007/s10585-014-9684-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
7 Steeg PS. Targeting metastasis. Nat Rev Cancer 2016;16:201-18. [PMID: 27009393 DOI: 10.1038/nrc.2016.25] [Cited by in Crossref: 671] [Cited by in F6Publishing: 637] [Article Influence: 111.8] [Reference Citation Analysis]
8 Kitamura T, Pollard JW. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer. Pharmacol Res 2015;100:266-70. [PMID: 26275794 DOI: 10.1016/j.phrs.2015.08.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
9 Song M, Sasazuki S, Camargo MC, Shimazu T, Charvat H, Yamaji T, Sawada N, Kemp TJ, Pfeiffer RM, Hildesheim A, Pinto LA, Rabkin CS, Tsugane S. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan. Int J Cancer 2018;143:2767-76. [PMID: 30132835 DOI: 10.1002/ijc.31821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sakai Y. Current topics in colorectal liver metastasis. Int J Clin Oncol 2011;16:451. [PMID: 21833682 DOI: 10.1007/s10147-011-0305-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Kigasawa H, Fujiwara M, Ishii J, Chiba T, Terado Y, Shimoyamada H, Mochizuki M, Kitamura O, Kamma H, Ohkura Y. Altered expression of cytokeratin 7 and CD117 in transitional mucosa adjacent to human colorectal cancer. Oncol Lett 2017;14:119-26. [PMID: 28693143 DOI: 10.3892/ol.2017.6156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Kraus S, Kolman T, Yeung A, Deming D. Chemokine Receptor Antagonists: Role in Oncology. Curr Oncol Rep 2021;23:131. [PMID: 34480662 DOI: 10.1007/s11912-021-01117-8] [Reference Citation Analysis]
13 Saxena S, Singh RK. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer Metastasis Rev 2021;40:447-76. [PMID: 33959849 DOI: 10.1007/s10555-021-09970-6] [Reference Citation Analysis]
14 Ruan X, Kocher JP, Pommier Y, Liu H, Reinhold WC. Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location. PLoS One 2012;7:e31628. [PMID: 22347499 DOI: 10.1371/journal.pone.0031628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
15 Rodero MP, Auvynet C, Poupel L, Combadière B, Combadière C. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. Neoplasia 2013;15:641-8. [PMID: 23730212 DOI: 10.1593/neo.121866] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
16 Cui C, Lan P, Fu L. The role of myeloid-derived suppressor cells in gastrointestinal cancer. Cancer Commun (Lond) 2021;41:442-71. [PMID: 33773092 DOI: 10.1002/cac2.12156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Janssen E, Subtil B, de la Jara Ortiz F, Verheul HMW, Tauriello DVF. Combinatorial Immunotherapies for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1875. [PMID: 32664619 DOI: 10.3390/cancers12071875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
18 Wieczorek E, Jablonska E, Wasowicz W, Reszka E. Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. Tumour Biol 2015;36:163-75. [PMID: 25352026 DOI: 10.1007/s13277-014-2747-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
19 Li BH, Jiang W, Zhang S, Huang N, Sun J, Yang J, Li ZF. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice. Mol Immunol 2020;125:95-103. [PMID: 32659598 DOI: 10.1016/j.molimm.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhu Y, Gao XM, Yang J, Xu D, Zhang Y, Lu M, Zhang Z, Sheng YY, Li JH, Yu XX, Zheng Y, Dong QZ, Qin LX. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma. Cancer Sci 2018;109:710-23. [PMID: 29285854 DOI: 10.1111/cas.13487] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
21 Jeong J, Suh Y, Jung K. Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment. Front Immunol 2019;10:1817. [PMID: 31474975 DOI: 10.3389/fimmu.2019.01817] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
22 Erkan EP, Ströbel T, Dorfer C, Sonntagbauer M, Weinhäusel A, Saydam N, Saydam O. Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation. Front Oncol 2019;9:1031. [PMID: 31649887 DOI: 10.3389/fonc.2019.01031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Liu Q, Liao Q, Zhao Y. Chemotherapy and tumor microenvironment of pancreatic cancer. Cancer Cell Int 2017;17:68. [PMID: 28694739 DOI: 10.1186/s12935-017-0437-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
24 Kiyasu Y, Kawada K, Hirai H, Ogawa R, Hanada K, Masui H, Nishikawa G, Yamamoto T, Mizuno R, Itatani Y, Kai M, Taketo MM, Sakai Y. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice. Cancer Lett 2020;487:53-62. [PMID: 32473241 DOI: 10.1016/j.canlet.2020.05.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chai WX, Sun LG, Dai FH, Shao HS, Zheng NG, Cai HY. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway. Pathol Res Pract 2019;215:152593. [PMID: 31471104 DOI: 10.1016/j.prp.2019.152593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Swamydas M, Ricci K, Rego SL, Dréau D. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases. Cell Adh Migr 2013;7:315-24. [PMID: 23722213 DOI: 10.4161/cam.25138] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
27 Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, Kato Y, Li J, Pollard JW. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212:1043-1059. [PMID: 26056232 DOI: 10.1084/jem.20141836] [Cited by in Crossref: 328] [Cited by in F6Publishing: 322] [Article Influence: 46.9] [Reference Citation Analysis]
28 Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R, Marshall JF, Panico MB, Shaw JA, Steeg PS, Sullivan M, Tong W, Westwell AD, Ritchie JWA; Cancer Research UK and Cancer Therapeutics CRC Australia Metastasis Working Group. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16:185-204. [PMID: 30514977 DOI: 10.1038/s41571-018-0134-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 29.0] [Reference Citation Analysis]
29 Zhao L, Zhu X, Ni Y, You J, Li A. Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo. Pharm Biol 2020;58:1085-91. [PMID: 33152259 DOI: 10.1080/13880209.2020.1839513] [Reference Citation Analysis]
30 Lionakis MS, Albert ND, Swamydas M, Lee CR, Loetscher P, Kontoyiannis DP. Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin. Antimicrob Agents Chemother 2017;61:e02365-16. [PMID: 27993850 DOI: 10.1128/AAC.02365-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
31 Ko SY, Blatch GL, Dass CR. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer. Cancer Metastasis Rev 2014;33:101-13. [PMID: 24338005 DOI: 10.1007/s10555-013-9459-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
32 Tauriello DV, Calon A, Lonardo E, Batlle E. Determinants of metastatic competency in colorectal cancer. Mol Oncol. 2017;11:97-119. [PMID: 28085225 DOI: 10.1002/1878-0261.12018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
33 Yang L, Li T, Shi H, Zhou Z, Huang Z, Lei X. The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis. Expert Review of Gastroenterology & Hepatology 2021;15:389-99. [DOI: 10.1080/17474124.2021.1848543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yin X, Han S, Song C, Zou H, Wei Z, Xu W, Ran J, Tang C, Wang Y, Cai Y, Hu Q, Han W. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells. Cell Oncol 2019;42:459-75. [DOI: 10.1007/s13402-019-00446-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
35 Owens P, Pickup MW, Novitskiy SV, Chytil A, Gorska AE, Aakre ME, West J, Moses HL. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc Natl Acad Sci U S A 2012;109:2814-9. [PMID: 21576484 DOI: 10.1073/pnas.1101139108] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
36 Ajina R, Malchiodi ZX, Fitzgerald AA, Zuo A, Wang S, Moussa M, Cooper CJ, Shen Y, Johnson QR, Parks JM, Smith JC, Catalfamo M, Fertig EJ, Jablonski SA, Weiner LM. Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. Cancer Immunol Res 2021;9:386-400. [PMID: 33509790 DOI: 10.1158/2326-6066.CIR-20-0272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Baniyash M. Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy. Cancer Immunol Immunother 2016;65:857-67. [PMID: 27225641 DOI: 10.1007/s00262-016-1849-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
38 Li M, Lai X, Zhao Y, Zhang Y, Li M, Li D, Kong J, Zhang Y, Jing P, Li H, Qin H, Shen L, Yao L, Li J, Dou K, Zhang J. Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization. Cell Death Dis 2018;9:248. [PMID: 29445150 DOI: 10.1038/s41419-018-0284-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
39 Jin K, Gao W, Lu Y, Lan H, Teng L, Cao F. Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncol Lett 2012;3:11-5. [PMID: 22740847 DOI: 10.3892/ol.2011.432] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
40 Vela M, Aris M, Llorente M, Garcia-Sanz JA, Kremer L. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front Immunol 2015;6:12. [PMID: 25688243 DOI: 10.3389/fimmu.2015.00012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
41 Valdivia-Silva J, Medina-Tamayo J, Garcia-Zepeda EA. Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents. Int J Mol Sci 2015;16:12958-85. [PMID: 26062132 DOI: 10.3390/ijms160612958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
42 Trovato R, Canè S, Petrova V, Sartoris S, Ugel S, De Sanctis F. The Engagement Between MDSCs and Metastases: Partners in Crime. Front Oncol 2020;10:165. [PMID: 32133298 DOI: 10.3389/fonc.2020.00165] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
43 Yan HH, Jiang J, Pang Y, Achyut BR, Lizardo M, Liang X, Hunter K, Khanna C, Hollander C, Yang L. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ. Cancer Res. 2015;75:5283-5298. [PMID: 26483204 DOI: 10.1158/0008-5472.CAN-15-2282-T] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
44 Zhao L, Lim SY, Gordon-Weeks AN, Tapmeier TT, Im JH, Cao Y, Beech J, Allen D, Smart S, Muschel RJ. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology. 2013;57:829-839. [PMID: 23081697 DOI: 10.1002/hep.26094] [Cited by in Crossref: 139] [Cited by in F6Publishing: 131] [Article Influence: 15.4] [Reference Citation Analysis]
45 Thanuja M Y, Anupama C, Ranganath SH. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far. Adv Drug Deliv Rev 2018;132:57-80. [PMID: 29935987 DOI: 10.1016/j.addr.2018.06.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
46 Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ, Sansom OJ. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest. 2012;122:3127-3144. [PMID: 22922255 DOI: 10.1172/jci61067] [Cited by in Crossref: 224] [Cited by in F6Publishing: 157] [Article Influence: 22.4] [Reference Citation Analysis]
47 Tabariès S, Ouellet V, Hsu BE, Annis MG, Rose AA, Meunier L, Carmona E, Tam CE, Mes-Masson AM, Siegel PM. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res 2015;17:45. [PMID: 25882816 DOI: 10.1186/s13058-015-0558-3] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 9.7] [Reference Citation Analysis]
48 Argyle D, Kitamura T. Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors. Front Immunol. 2018;9:2629. [PMID: 30483271 DOI: 10.3389/fimmu.2018.02629] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
49 Batlle E, Massagué J. Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity 2019;50:924-40. [PMID: 30995507 DOI: 10.1016/j.immuni.2019.03.024] [Cited by in Crossref: 410] [Cited by in F6Publishing: 442] [Article Influence: 136.7] [Reference Citation Analysis]
50 Zhou Y, Han M, Gao J. Prognosis and targeting of pre-metastatic niche. J Control Release 2020;325:223-34. [PMID: 32629136 DOI: 10.1016/j.jconrel.2020.06.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Schcolnik-Cabrera A, Dominguez-Gómez G, Chávez-Blanco A, Ramírez-Yautentzi M, Morales-Bárcenas R, Chávez-Díaz J, Taja-Chayeb L, Dueáas-González A. A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells. Oncol Lett 2019;18:6909-16. [PMID: 31788130 DOI: 10.3892/ol.2019.11008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
52 Itatani Y, Kawada K, Sakai Y. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment. Int J Mol Sci 2019;20:E5822. [PMID: 31756952 DOI: 10.3390/ijms20235822] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
53 Ji J, Xu J, Zhao S, Liu F, Qi J, Song Y, Ren J, Wang T, Dou H, Hou Y. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs. Clin Sci (Lond) 2016;130:1453-67. [PMID: 27231253 DOI: 10.1042/CS20160311] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
54 Taketo MM. Roles of stromal microenvironment in colon cancer progression. J Biochem 2012;151:477-81. [PMID: 22496483 DOI: 10.1093/jb/mvs035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
55 Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49-61. [PMID: 25035953 DOI: 10.1016/j.immuni.2014.06.010] [Cited by in Crossref: 1797] [Cited by in F6Publishing: 1791] [Article Influence: 224.6] [Reference Citation Analysis]
56 Ang AD, Vissers MCM, Burgess ER, Currie MJ, Dachs GU. Gene and Protein Expression Is Altered by Ascorbate Availability in Murine Macrophages Cultured under Tumour-Like Conditions. Antioxidants (Basel) 2021;10:430. [PMID: 33799728 DOI: 10.3390/antiox10030430] [Reference Citation Analysis]
57 Bule P, Aguiar SI, Aires-Da-Silva F, Dias JNR. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Int J Mol Sci 2021;22:9804. [PMID: 34575965 DOI: 10.3390/ijms22189804] [Reference Citation Analysis]
58 Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer 2016;16:431-46. [PMID: 27282249 DOI: 10.1038/nrc.2016.52] [Cited by in Crossref: 652] [Cited by in F6Publishing: 646] [Article Influence: 108.7] [Reference Citation Analysis]
59 Kawada K, Hasegawa S, Murakami T, Itatani Y, Hosogi H, Sonoshita M, Kitamura T, Fujishita T, Iwamoto M, Matsumoto T. Molecular mechanisms of liver metastasis. Int J Clin Oncol. 2011;16:464-472. [PMID: 21847533 DOI: 10.1007/s10147-011-0307-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
60 Horimoto Y, Polanska UM, Takahashi Y, Orimo A. Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr 2012;6:193-202. [PMID: 22568980 DOI: 10.4161/cam.20631] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
61 Mishra PK, Teale JM. Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis. PLoS Negl Trop Dis 2013;7:e2099. [PMID: 23516647 DOI: 10.1371/journal.pntd.0002099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
62 Meirow Y, Kanterman J, Baniyash M. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate. Front Immunol 2015;6:523. [PMID: 26528286 DOI: 10.3389/fimmu.2015.00523] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
63 Wang Y, Ding Y, Guo N, Wang S. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation. Front Immunol 2019;10:172. [PMID: 30792719 DOI: 10.3389/fimmu.2019.00172] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
64 Du J, Flynn R, Paz K, Ren HG, Ogata Y, Zhang Q, Gafken PR, Storer BE, Roy NH, Burkhardt JK, Mathews W, Tolar J, Lee SJ, Blazar BR, Paczesny S. Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood. 2018;131:1743-1754. [PMID: 29348127 DOI: 10.1182/blood-2017-08-800623] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
65 Liu F, Wu H. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets. J Inflamm Res 2021;14:267-85. [PMID: 33574689 DOI: 10.2147/JIR.S278395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Vallet S, Anderson KC. CCR1 as a target for multiple myeloma. Expert Opin Ther Targets. 2011;15:1037-1047. [PMID: 21609295 DOI: 10.1517/14728222.2011.586634] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
67 Lee YS, Cho YB. CCL7 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2020;1231:33-43. [PMID: 32060844 DOI: 10.1007/978-3-030-36667-4_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Trappetti V, Fazzari JM, Fernandez-Palomo C, Scheidegger M, Volarevic V, Martin OA, Djonov VG. Microbeam Radiotherapy-A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma. Int J Mol Sci 2021;22:7755. [PMID: 34299373 DOI: 10.3390/ijms22147755] [Reference Citation Analysis]
69 Zheng W, Wu F, Fu K, Sun G, Sun G, Li X, Jiang W, Cao H, Wang H, Tang W. Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer. Onco Targets Ther 2021;14:3013-36. [PMID: 33986602 DOI: 10.2147/OTT.S301371] [Reference Citation Analysis]
70 Itatani Y, Kawada K, Fujishita T, Kakizaki F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa S, Maekawa T, Uemoto S, Sakai Y, Taketo MM. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology 2013;145:1064-1075.e11. [PMID: 23891973 DOI: 10.1053/j.gastro.2013.07.033] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
71 Gudiño V, Pohl SÖ, Billard CV, Cammareri P, Bolado A, Aitken S, Stevenson D, Hall AE, Agostino M, Cassidy J, Nixon C, von Kriegsheim A, Freile P, Popplewell L, Dickson G, Murphy L, Wheeler A, Dunlop M, Din F, Strathdee D, Sansom OJ, Myant KB. RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways. Nat Commun 2021;12:2335. [PMID: 33879799 DOI: 10.1038/s41467-021-22531-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zhou J, Xiang Y, Yoshimura T, Chen K, Gong W, Huang J, Zhou Y, Yao X, Bian X, Wang JM. The role of chemoattractant receptors in shaping the tumor microenvironment. Biomed Res Int 2014;2014:751392. [PMID: 25110692 DOI: 10.1155/2014/751392] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
73 Kato T, Fujita Y, Nakane K, Mizutani K, Terazawa R, Ehara H, Kanimoto Y, Kojima T, Nozawa Y, Deguchi T, Ito M. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling. Cytokine 2013;64:251-7. [PMID: 23876400 DOI: 10.1016/j.cyto.2013.06.313] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
74 Itatani Y, Kawada K, Inamoto S, Yamamoto T, Ogawa R, Taketo MM, Sakai Y. The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis. Int J Mol Sci 2016;17:E643. [PMID: 27136535 DOI: 10.3390/ijms17050643] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
75 Erez N, Coussens LM. Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer 2011;128:2536-44. [PMID: 21387299 DOI: 10.1002/ijc.26032] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
76 Ciner AT, Jones K, Muschel RJ, Brodt P. The unique immune microenvironment of liver metastases: Challenges and opportunities. Semin Cancer Biol 2021;71:143-56. [PMID: 32526354 DOI: 10.1016/j.semcancer.2020.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Giakoustidis A, Mudan S, Hagemann T. Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway. Cancer Microenviron 2015;8:177-86. [PMID: 25277516 DOI: 10.1007/s12307-014-0155-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
78 Richter R, Rüster B, Bistrian R, Forssmann WG, Seifried E, Henschler R. Beta-Chemokine CCL15 Affects the Adhesion and Migration of Hematopoietic Progenitor Cells. Transfus Med Hemother 2015;42:29-37. [PMID: 25960713 DOI: 10.1159/000370168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
79 Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract. 2015;211:557-569. [PMID: 26092594 DOI: 10.1016/j.prp.2015.05.010] [Cited by in Crossref: 164] [Cited by in F6Publishing: 177] [Article Influence: 23.4] [Reference Citation Analysis]
80 Jiang D, Lim SY. Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis. Cancer Microenviron 2016;9:45-61. [PMID: 26956475 DOI: 10.1007/s12307-016-0181-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
81 Huber T, Sakmar TP. Escaping the flatlands: new approaches for studying the dynamic assembly and activation of GPCR signaling complexes. Trends Pharmacol Sci 2011;32:410-9. [PMID: 21497404 DOI: 10.1016/j.tips.2011.03.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
82 Li BH, Garstka MA, Li ZF. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol Immunol 2020;117:201-15. [PMID: 31835202 DOI: 10.1016/j.molimm.2019.11.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
83 Quante M, Varga J, Wang TC, Greten FR. The gastrointestinal tumor microenvironment. Gastroenterology. 2013;145:63-78. [PMID: 23583733 DOI: 10.1053/j.gastro.2013.03.052] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 9.9] [Reference Citation Analysis]
84 Mollica Poeta V, Massara M, Capucetti A, Bonecchi R. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy. Front Immunol. 2019;10:379. [PMID: 30894861 DOI: 10.3389/fimmu.2019.00379] [Cited by in Crossref: 130] [Cited by in F6Publishing: 126] [Article Influence: 43.3] [Reference Citation Analysis]
85 Edwards SC, Hoevenaar WHM, Coffelt SB. Emerging immunotherapies for metastasis. Br J Cancer 2021;124:37-48. [PMID: 33262520 DOI: 10.1038/s41416-020-01160-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
86 Vansaun MN, Mendonsa AM, Lee Gorden D. Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. PLoS One. 2013;8:e73054. [PMID: 24039859 DOI: 10.1371/journal.pone.0073054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
87 Korbecki J, Kojder K, Simińska D, Bohatyrewicz R, Gutowska I, Chlubek D, Baranowska-Bosiacka I. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. Int J Mol Sci 2020;21:E8412. [PMID: 33182504 DOI: 10.3390/ijms21218412] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
88 Salomonsson M, Dahlin JS, Ungerstedt J, Hallgren J. Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors. Front Immunol 2020;11:321. [PMID: 32174921 DOI: 10.3389/fimmu.2020.00321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chen J, Dang Y, Feng W, Qiao C, Liu D, Zhang T, Wang Y, Tian D, Fan D, Nie Y, Wu K, Xia L. SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7. Oncogene 2020;39:5536-52. [PMID: 32616889 DOI: 10.1038/s41388-020-1378-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Liu JJ, Li LZ, Xu P. Upregulation of TRPM8 can promote the colon cancer liver metastasis through mediating Akt/GSK-3 signal pathway. Biotechnol Appl Biochem 2021. [PMID: 33432591 DOI: 10.1002/bab.2102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Chioda M, Peranzoni E, Desantis G, Papalini F, Falisi E, Solito S, Mandruzzato S, Bronte V. Myeloid cell diversification and complexity: an old concept with new turns in oncology. Cancer Metastasis Rev. 2011;30:27-43. [PMID: 21267772 DOI: 10.1007/s10555-011-9268-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
92 Ehling J, Tacke F. Role of chemokine pathways in hepatobiliary cancer. Cancer Lett. 2015; Jun 26. [Epub ahead of print]. [PMID: 26123664 DOI: 10.1016/j.canlet.2015.06.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
93 Sheng H, Li X, Xu Y. Knockdown of FOXP1 promotes the development of lung adenocarcinoma. Cancer Biol Ther 2019;20:537-45. [PMID: 30409062 DOI: 10.1080/15384047.2018.1537999] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
94 Deguchi A, Tomita T, Ohto U, Takemura K, Kitao A, Akashi-takamura S, Miyake K, Maru Y. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment. Oncogene 2016;35:1445-56. [DOI: 10.1038/onc.2015.211] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
95 Medina-Echeverz J, Eggert T, Han M, Greten TF. Hepatic myeloid-derived suppressor cells in cancer. Cancer Immunol Immunother 2015;64:931-40. [PMID: 26133122 DOI: 10.1007/s00262-015-1736-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]